Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study

Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 71:209–249

PubMed  Google Scholar 

Land L, Dalton S, Jensen M et al (2012) Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer. Br J Cancer 107:1901–1907

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mehta LS, Watson KE, Barac A et al (2018) Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation 137:e30–e66

Article  PubMed  PubMed Central  Google Scholar 

Ministry of Health (2019) Annual Update of Key Results 2018/19: New Zealand Health Survey. Ministry of Health, Wellington

Google Scholar 

Ford ES, Li C, Zhao G et al (2010) Trends in low-risk lifestyle factors among adults in the United States: findings from the Behavioral Risk Factor Surveillance System 1996–2007. Prev Med 51:403–407

Article  PubMed  Google Scholar 

Feingold KR (2021) Cholesterol lowering drugs. Endotext

Baigent C, Keech A, Kearney PM et al (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 366:1267–1278

Article  CAS  PubMed  Google Scholar 

Ehmsen S, Pedersen MH, Wang G et al (2019) Increased cholesterol biosynthesis is a key characteristic of breast cancer stem cells influencing patient outcome. Cell Rep 27(3927–3938):e6

Google Scholar 

Borgquist S, Djerbi S, Pontén F et al (2008) HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors. Int J Cancer 123:1146–1153

Article  CAS  PubMed  Google Scholar 

Beckwitt CH, Brufsky A, Oltvai ZN et al (2018) Statin drugs to reduce breast cancer recurrence and mortality. Breast Cancer Res 20:1–11

Article  Google Scholar 

Blanco-Colio LM, Tuñón J, Martín-Ventura JL et al (2003) Anti-inflammatory and immunomodulatory effects of statins. Kidney Int 63:12–23

Article  CAS  PubMed  Google Scholar 

Bellosta S, Bernini F, Paoletti R et al (2000) Non-lipid-related effects of statins. Ann Med 32:164–176

Article  CAS  PubMed  Google Scholar 

Beckwitt CH, Clark AM, Ma B et al (2018) Statins attenuate outgrowth of breast cancer metastases. Br J Cancer 119:1094–1105

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghosh-Choudhury N, Mandal CC, Ghosh-Choudhury N et al (2010) Simvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growth. Cell Signal 22:749–758

Article  CAS  PubMed  PubMed Central  Google Scholar 

Campbell MJ, Esserman LJ, Zhou Y et al (2006) Breast cancer growth prevention by statins. Can Res 66:8707–8714

Article  CAS  Google Scholar 

Borgquist S, Broberg P, Tojjar J et al (2019) Statin use and breast cancer survival–a Swedish nationwide study. BMC Cancer 19:1–9

Article  Google Scholar 

Smith A, Murphy L, Zgaga L et al (2017) Pre-diagnostic statin use, lymph node status and mortality in women with stages I-III breast cancer. Br J Cancer 117:588–596

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murtola TJ, Visvanathan K, Artama M et al (2014) Statin use and breast cancer survival: a nationwide cohort study from Finland. PLoS ONE 9:e110231

Article  PubMed  PubMed Central  Google Scholar 

Hosio M, Urpilainen E, Hautakoski A, Marttila M, Arffman M, Sund R, Ahtikoski A, Puistola U, Karihtala P, Jukkola A, Läärä E (2020) Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study. Acta Oncologica 59(9):1110–1117

Nowakowska MK, Lei X, Thompson MT et al (2021) Association of statin use with clinical outcomes in patients with triple-negative breast cancer. Cancer 127:4142–4150

Article  CAS  PubMed  Google Scholar 

Nielsen SF, Nordestgaard BG, Bojesen SE (2012) Statin use and reduced cancer-related mortality. N Engl J Med 367:1792–1802

Article  CAS  PubMed  Google Scholar 

Haukka J, Niskanen L, Auvinen A (2017) Risk of cause-specific death in individuals with cancer—modifying role diabetes, statins and metformin. Int J Cancer 141:2437–2449

Article  CAS  PubMed  Google Scholar 

Cardwell CR, Hicks BM, Hughes C et al (2015) Statin use after diagnosis of breast cancer and survival: a population-based cohort study. Epidemiology 26:68–78

Article  PubMed  Google Scholar 

Mc Menamin ÚC, Murray LJ, Hughes CM et al (2016) Statin use and breast cancer survival: a nationwide cohort study in Scotland. BMC Cancer 16:1–11

Article  Google Scholar 

Smith A, Murphy L, Sharp L et al (2016) De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage i–iii breast cancer. Br J Cancer 115:592–598

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bjarnadottir O, Feldt M, Inasu M et al (2020) Statin use, HMGCR expression, and breast cancer survival—the Malmö Diet and Cancer Study. Sci Rep 10:1–10

Article  Google Scholar 

Brewer T, Masuda H, Liu D et al (2013) Statin use in primary inflammatory breast cancer: a cohort study. Br J Cancer 109:318–324

Article  CAS  PubMed  PubMed Central  Google Scholar 

Desai P, Lehman A, Chlebowski RT et al (2015) Statins and breast cancer stage and mortality in the Women’s Health Initiative. Cancer Causes Control 26:529–539

Article  PubMed  PubMed Central  Google Scholar 

Nickels S, Vrieling A, Seibold P et al (2013) Mortality and recurrence risk in relation to the use of lipid-lowering drugs in a prospective breast cancer patient cohort. PLoS ONE 8:e75088

Article  CAS  PubMed  PubMed Central  Google Scholar 

Botteri E, Munzone E, Rotmensz N et al (2013) Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women. Breast Cancer Res Treat 140:567–575

Article  CAS  PubMed  Google Scholar 

Sim Y, Lim C, Phyu N et al (2022) The impact of statin use and breast cancer recurrence—a retrospective study in Singapore. Front Oncol 12:835320. https://doi.org/10.3389/fonc.2022.835320

Shaitelman SF, Stauder MC, Allen P et al (2017) Impact of statin use on outcomes in triple negative breast cancer. J Cancer 8:2026

Article  PubMed  PubMed Central  Google Scholar 

Ahern TP, Pedersen L, Tarp M et al (2011) Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst 103:1461–1468

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chae YK, Valsecchi ME, Kim J et al (2011) Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins. Cancer Invest 29:585–593

Article  CAS  PubMed  Google Scholar 

Lacerda L, Reddy JP, Liu D et al (2014) Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation. Stem Cells Transl Med 3:849–856

Article  CAS  PubMed  PubMed Central  Google Scholar 

Inasu M, Feldt M, Jernström H et al (2022) Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study. Breast 61:123–128. https://doi.org/10.1016/j.breast.2022.01.003

Kwan ML, Habel LA, Flick ED et al (2008) Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat 109:573–579

Article  CAS  PubMed  Google Scholar 

Boudreau DM, Yu O, Chubak J et al (2014) Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer. Breast Cancer Res Treat 144:405–416

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakellakis M, Akinosoglou K, Kostaki A et al (2016) Statins and risk of breast cancer recurrence. Breast Cancer: Targets Therapy 8:199

PubMed  Google Scholar 

Harborg S, Heide-Jørgensen U, Ahern TP et al (2020) Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study. Breast Cancer Res Treat 183:153–160

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li YR, Ro V, Steel L et al (2019) Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancer. Breast Cancer Res Treat 176:669–677

Tryggvadottir H, Huzell L, Gustbée E et al (2018) Interactions between ABCB1 genotype and preoperative statin use impact clinical outcomes among breast cancer patients. Front Oncol 428

Garwood ER, Kumar AS, Baehner FL et al (2010) Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat 119:137–144

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bjarnadottir O, Rome

留言 (0)

沒有登入
gif